Status:

COMPLETED

Metformin as Adjuvant to Insulin Therapy in Insulin-resistant Diabetes Mellitus With Pregnancy

Lead Sponsor:

Ain Shams University

Conditions:

Diabetes Mellitus

Eligibility:

FEMALE

20-45 years

Phase:

PHASE3

Brief Summary

Adding metformin to insulin therapy in pregnant women with diabetes mellitus who show insulin resistance may be equivalently effective to further raising the insulin dose

Eligibility Criteria

Inclusion

  • pregnant women with insulin-resistant diabetes mellitus

Exclusion

  • type-1 diabetes mellitus
  • secondary diabetes mellitus

Key Trial Info

Start Date :

April 1 2012

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 1 2013

Estimated Enrollment :

90 Patients enrolled

Trial Details

Trial ID

NCT01915550

Start Date

April 1 2012

End Date

February 1 2013

Last Update

August 5 2013

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Ain Shams University Maternity Hospital

Cairo, Cairo Governorate, Egypt, 19931

Metformin as Adjuvant to Insulin Therapy in Insulin-resistant Diabetes Mellitus With Pregnancy | DecenTrialz